ALNA
NASDAQAllena Pharmaceuticals Inc.
Latest news
25 items- SECSEC Form SEC STAFF ACTION filed by Allena Pharmaceuticals Inc.SEC STAFF ACTION - Allena Pharmaceuticals, Inc. (0001624658) (Filer)
- 13D/GSEC Form SC 13G/A filed by Allena Pharmaceuticals Inc. (Amendment)SC 13G/A - Allena Pharmaceuticals, Inc. (0001624658) (Subject)
- SECSEC Form NT 10-Q filed by Allena Pharmaceuticals Inc.NT 10-Q - Allena Pharmaceuticals, Inc. (0001624658) (Filer)
- SECSEC Form 25-NSE filed by Allena Pharmaceuticals Inc.25-NSE - Allena Pharmaceuticals, Inc. (0001624658) (Subject)
- SECAllena Pharmaceuticals Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Allena Pharmaceuticals, Inc. (0001624658) (Filer)
- NEWSWhy Korn Ferry Is Trading Lower By Over 8%, Here Are 40 Stocks Moving In Wednesday's Mid-Day SessionGainers Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) jumped 64% to $0.1199. Allena Pharmaceuticals shares dipped over 30% on Tuesday after the company announced it has filed for bankruptcy. Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) shares surged 44.3% to $4.7893 after Alliance Global Partners initiated coverage on the stock with a Buy rating and a $20 price target. IMARA Inc. (NASDAQ:IMRA) rose 37% to $1.57 after the company announced it entered into an asset purchase agreement with Cardurion Pharmaceuticals to sell tovinontrine and other assets of its PDE9 program for $34.75 million upfront. Sidus Space, Inc. (NASDAQ:SIDU) gained 26.7% to $3.3701 after the company announced that it has
- NEWSAllena Pharmaceuticals shares are trading higher after the stock dipped on Tuesday following news the company has filed for bankruptcy.
- NEWS12 Health Care Stocks Moving In Wednesday's Pre-Market SessionGainers BioVie (NASDAQ:BIVI) stock increased by 32.3% to $4.55 during Wednesday's pre-market session. The company's market cap stands at $130.2 million. bioAffinity Technologies (NASDAQ:BIAF) shares increased by 30.61% to $7.04. The market value of their outstanding shares is at $19.2 million. Imara (NASDAQ:IMRA) stock moved upwards by 23.93% to $1.45. The market value of their outstanding shares is at $38.1 million. Quoin Pharmaceuticals (NASDAQ:QNRX) stock moved upwards by 18.37% to $3.93. The market value of their outstanding shares is at $18.8 million. Spero Therapeutics (NASDAQ:SPRO) shares increased by 17.69% to $1.33. The company's market cap stands at $46.6 million. iSpeci
- NEWSWhy Coupa Software Is Trading Higher By Over 12%; Here Are 24 Stocks Moving PremarketGainers Biophytis S.A. (NASDAQ:BPTS) shares rose 41.5% to $1.33 in pre-market trading after the company announced data on Covid treatment. bioAffinity Technologies, Inc. (NASDAQ:BIAF) rose 26.4% to $6.81 in pre-market trading after dropping around 24% on Tuesday. The company, last week, priced its IPO at $6.125 per unit. Spero Therapeutics, Inc. (NASDAQ:SPRO) shares rose 20.4% to $1.36 in pre-market trading. Spero Therapeutics shares jumped over 55% on Tuesday after the company received minutes from a Type A meeting with the FDA discussing steps required to resubmit the marketing application for tebipenem HBr. Coupa Software Incorporated (NASDAQ:COUP) rose 12.2% to $62.60 in pre-mark
- NEWSWhy Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From YesterdayGainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility. IVERIC bio, Inc. (NASDAQ:ISEE) rose 66.3% to close at $15.70 on Tuesday after the company announced positive data from the second Phase 3 trial of Zimura (avacincaptad pegol) for geographic atrophy (GA). HyreCar Inc. (NASDAQ:HYRE) climbed 58.1% to close at $1.27 on Tuesday after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist Partners. Spero Therapeutics, Inc. (NASDAQ:SPRO) gained 55.5% to close at $1.13. Spero Therapeutics received minutes from a recent Type A meeting wi
- NEWSDow Tumbles Over 200 Points; ChannelAdvisor Shares Spike HigherU.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 200 points on Tuesday. All the three major indices recorded their third weekly loss in a row, with the Dow dropping around 3%, and the S&P 500 down around 3.3%. The Dow traded down 0.71% to 31,095.92 while the NASDAQ fell 0.90% to 11,526.66. The S&P 500 also fell, dropping, 0.57% to 3,902.02. Also check this: US Stocks Record Third Consecutive Weekly Loss But Market Volatility Decreases Leading and Lagging Sectors Real estate shares jumped by 0.9% on Tuesday. Meanwhile, top gainers in the sector included Outfront Media Inc. (NYSE:OUT), up 7% and IRSA Inversiones y Representaciones Sociedad Anó
- NEWS12 Health Care Stocks Moving In Tuesday's Intraday SessionGainers Spero Therapeutics (NASDAQ:SPRO) shares increased by 134.6% to $1.71 during Tuesday's regular session. Spero Therapeutics's stock is trading at a volume of 34.7 million shares as of 13:31 EST. This is 12229.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $59.7 million. Shuttle Pharmaceuticals (NASDAQ:SHPH) shares rose 71.43% to $25.54. Trading volume for Shuttle Pharmaceuticals's stock is 11.3 million as of 13:31 EST. This is 577.6% of its average full-day volume over the last 100 days. The company's market cap stands at $339.3 million. IVERIC bio (NASDAQ:ISEE) stock increased by 56.67% to $14.79. As of 13:31 EST, I
- NEWSNasdaq Drops 100 Points; DWAC Shares PlummetU.S. stocks traded lower midway through trading, with the Nasdaq dropping over 100 points on Tuesday. All the three major indices recorded their third weekly loss in a row, with the Dow dropping around 3%, and the S&P 500 down around 3.3%. The Dow traded down 0.62% to 31,122.76 while the NASDAQ fell 0.92% to 11,523.57. The S&P 500 also fell, dropping, 0.58% to 3,901.65. Also check this: US Stocks Record Third Consecutive Weekly Loss But Market Volatility Decreases Leading and Lagging Sectors Utilities shares jumped by 1.2% on Tuesday. Meanwhile, top gainers in the sector included Enel Chile S.A. (NYSE:ENIC), up 8% and Azure Power Global Limited (NYSE:AZRE) up 7%. In trading on Tu
- NEWSWhy HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day SessionGainers HyreCar Inc. (NASDAQ:HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist Partners. ChannelAdvisor Corporation (NYSE:ECOM) shares climbed 54.9% to $22.77 after the company announced it will be acquired by CommerceHub for $23.10 per share IVERIC bio, Inc. (NASDAQ:ISEE) gained 41.4% to $13.35 after the company announced positive data from the second Phase 3 trial of Zimura (avacincaptad pegol) for geographic atrophy (GA). Nutex Health, Inc. (NASDAQ:NUTX) rose 39% to $3.33. Nutex Health recently reported Q2 earnings results. Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:
- NEWS12 Health Care Stocks Moving In Tuesday's Pre-Market SessionGainers IVERIC bio (NASDAQ:ISEE) stock increased by 35.7% to $12.81 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.5 billion. Organovo Holdings (NASDAQ:ONVO) stock increased by 20.99% to $2.79. The market value of their outstanding shares is at $24.3 million. First Wave BioPharma (NASDAQ:FWBI) shares rose 18.86% to $3.78. The market value of their outstanding shares is at $5.2 million. Universe Pharmaceuticals (NASDAQ:UPC) shares increased by 16.53% to $0.64. The market value of their outstanding shares is at $13.9 million. Rubius Therapeutics (NASDAQ:RUBY) shares increased by 15.62% to $1.07. The company's market cap stands at $96.6 mill
- NEWSAllena Pharmaceuticals shares are trading lower after the company announced it has filed for bankruptcy.
- NEWSAllena Pharmaceuticals Shares Fall After Filing For BankruptcyIn its SEC filing, Allena Pharmaceuticals Inc (NASDAQ:ALNA) filed for chapter 11 bankruptcy protection and terminated the employment of substantially all of its employees. In January, the company announced exploring strategic and financing alternatives. The company terminated substantially all of its employees, including Louis Brenner, President and Chief Executive Officer of the Company, and Richard D. Katz, Chief Financial Officer. The company said it intends to continue operating at a reduced level. Allena expects the filing to cancel or extinguish all outstanding shares without any payment or other distribution. After receiving a Nasdaq delisting warning, Allena requested a heari
- NEWSWhy DWAC Is Trading Lower By Around 19%; Here Are 32 Stocks Moving PremarketGainers First Wave BioPharma, Inc. (NASDAQ:FWBI) shares rose 39.6% to $4.44 in pre-market trading after gaining 7% on Friday. Organovo Holdings, Inc. (NASDAQ:ONVO) rose 25.1% to $2.89 in pre-market trading. Tian Ruixiang Holdings Ltd (NASDAQ:TIRX) shares rose 24% to $0.85 in pre-market trading after declining around 5% on Friday. Rubius Therapeutics, Inc. (NASDAQ:RUBY) rose 16.7% to $1.08 in pre-market trading after climbing over 23% on Friday. CytomX Therapeutics, Inc. (NASDAQ:CTMX) rose 15.1% to $1.68 in pre-market trading. CytomX Therapeutics, last month, posted a Q2 loss of $0.37 per share. GlycoMimetics, Inc. (NASDAQ:GLYC) rose 15% to $0.85 in pre-market trading. The company
- SECAllena Pharmaceuticals Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Bankruptcy or Receivership, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Leadership Update8-K - Allena Pharmaceuticals, Inc. (0001624658) (Filer)
- SECAllena Pharmaceuticals Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Allena Pharmaceuticals, Inc. (0001624658) (Filer)
- SECSEC Form 10-Q filed by Allena Pharmaceuticals Inc.10-Q - Allena Pharmaceuticals, Inc. (0001624658) (Filer)
- NEWS12 Health Care Stocks Moving In Friday's After-Market SessionGainers Axcella Health (NASDAQ:AXLA) shares rose 25.5% to $3.0 during Friday's after-market session. The market value of their outstanding shares is at $157.7 million. As per the press release, Q2 earnings came out today. Fortress Biotech (NASDAQ:FBIO) stock increased by 8.66% to $1.38. The market value of their outstanding shares is at $148.2 million. As per the news, the Q2 earnings report came out yesterday. Aquestive Therapeutics (NASDAQ:AQST) stock increased by 6.93% to $1.85. Aquestive Therapeutics's trading volume hit 169.2K shares by close, accounting for 19.7% of its average volume over the last 100 days. The company's market cap stands at $98.6 million. Allena Pharma (NASD
- NEWSAllena Pharma Needs To Raise Capital To Continue As A Going ConcernAllena Pharmaceuticals Inc (NASDAQ:ALNA) says it lacks the financial resources to conduct studies for ALLN-346 for hyperuricemia and gout in the setting of advanced chronic kidney disease. The company continues to evaluate the data from cohorts A and B of Study 202 and the long-term viability of the ALLN-346 clinical program. In light of the clinical data observed to date, in particular the data from Study 201, which demonstrated a potential GI-based mechanism of action, it is possible that the clinical effect could be more pronounced in a more acute patient population (cohort C) or when used in combination with allopurinol (cohort D). However, Allena currently lacks the financial res
- NEWSAllena Pharmaceuticals Says Needs To Raise Capital Imminently To Continue As A Going Concern-SEC Filingh
- SECAllena Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Allena Pharmaceuticals, Inc. (0001624658) (Filer)
ALNA FAQ
6 questionsWhat does Allena Pharmaceuticals Inc. do?
Allena Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, engages in the development and commercialization of oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. The company's lead product candidate is reloxaliase, an oral enzyme therapeutic that is in phase 3 clinical program for the treatment of hyperoxaluria, a metabolic disorder commonly associated with kidney stones in adults. It also develops ALLN-346, a novel and urate degrading enzyme for patients with hyperuricemia and moderate to severe chronic...Where does ALNA stock trade?
Allena Pharmaceuticals Inc. (ALNA) is listed on NASDAQ.What sector and industry is ALNA in?
Allena Pharmaceuticals Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Allena Pharmaceuticals Inc. go public?
Allena Pharmaceuticals Inc. (ALNA) completed its IPO in 2017.What companies are similar to ALNA?
Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare ALNA side-by-side with any of them on Quantisnow.How can I track ALNA on Quantisnow?
Quantisnow aggregates Allena Pharmaceuticals Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ALNA to receive live email and push alerts on every new disclosure.